Anthony Mancini Sells $432K of Revolution Medicines Inc (RVMD) — SEC Form 4, Oct 28, 2026

Open-Market Net Sale · SEC Form 4

−$431,947

10b5-1 Plan

Reporting Owner

Anthony Mancini

Officer

TXN 2026-10-26 · FILED 2026-10-28

Equity Position 42.1K sh 42,075 → 42,075

Filing Lag 2 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Revolution Medicines Inc

RVMD CIK 0001628171

Reporting Owner

Name	Relationship
Anthony Mancini CIK 0002124509	Officer

Anthony Mancini at Revolution Medicines Inc Full insider history

Bought (12 mo) —

Sold (12 mo) $10,222,941

More from this insider at Revolution Medicines Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common StockF1	2026-10-26	M - Exercise 10b5-1	2,310 A	$33.62	+$77,662	42,075	Direct
Common StockF1 F2	2026-10-26	S - Sale 10b5-1	2,310 D	$186.99	-$431,947	39,765	Direct

Derivative Securities Transactions

Title	Strike	Date	Type	Shares	Price	Expiration	Underlying	Ownership
Stock Option (Right to Buy)F1 F3	$33.62	2026-10-26	M - Exercise 10b5-1	2,310 D	$0.00	2035-04-01	106,109 Common Stock	Direct

Footnotes (3)

F1: Transaction made pursuant to a 10b5-1 trading plan adopted by Anthony Mancini on June 11, 2026. Show more
F2: Includes 39,575 restricted stock units. Show more
F3: Twenty-five percent of the total shares subject to the option will vest on the first year anniversary measured from April 1, 2025 (the "Vesting Commencement Date") and one forty-eighth (1/48th) of the shares subject to the option will vest on each monthly anniversary of the Vesting Commencement Date thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date. Show more